Indication
Grade 1 Follicular Lymphoma
3 clinical trials
1 product
1 drug
Clinical trial
The Asymptomatic Follicular Lymphoma (AFL) Trial: A Phase III Study of Single-Agent Rituximab Immunotherapy Versus Zevalin Radioimmunotherapy for Patients With New, Untreated Follicular Lymphoma Who Are Candidates for ObservationStatus: Completed, Estimated PCD: 2021-02-28
Drug
VarlilumabClinical trial
Ultra Low Dose 4 Gy Orbital Radiation for Definitive Therapy of Indolent B Cell LymphomaStatus: Active (not recruiting), Estimated PCD: 2025-06-30
Product
Orbital RadiationClinical trial
Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/IIStatus: Recruiting, Estimated PCD: 2027-05-20